Permian Basin Royalty Trust (PBT)

4.76
0.24 4.80
NYSE : Energy Minerals
Prev Close 5.00
Open 4.92
Day Low/High 4.74 / 5.00
52 Wk Low/High 4.75 / 9.04
Volume 129.49K
Avg Volume 120.20K
Exchange NYSE
Shares Outstanding 46.61M
Market Cap 228.85M
EPS 0.70
P/E Ratio 4.81
Div & Yield 0.48 (10.10%)

Latest News

Permian Basin Royalty Trust (PBT) Shares Cross Below Book Value

Permian Basin Royalty Trust (PBT) Shares Cross Below Book Value

In trading on Wednesday, shares of Permian Basin Royalty Trust crossed below their last reported book value — defined as common shareholder equity per share — of $5.00, changing hands as low as $4.96 per share. Permian Basin Royalty Trust shares are currently trading up about 0.6% on the day.

Permian Basin Royalty Trust Announces July Cash Distribution

Permian Basin Royalty Trust Announces July Cash Distribution

DALLAS, July 19, 2019 /PRNewswire/ -- Simmons Bank, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) ("Permian") today declared a cash distribution to the holders of its units of beneficial interest of $0.

Ex-Div Reminder For Permian Basin Royalty Trust (PBT)

Ex-Div Reminder For Permian Basin Royalty Trust (PBT)

Looking at the universe of stocks we cover at Dividend Channel, on 6/27/19, Permian Basin Royalty Trust will trade ex-dividend, for its monthly dividend of $0.0397, payable on 7/15/19. As a percentage of PBT's recent stock price of $5.86, this dividend works out to approximately 0.68%, so look for shares of Permian Basin Royalty Trust to trade 0.68% lower — all else being equal — when PBT shares open for trading on 6/27/19.

Permian Basin Royalty Trust Announces June Cash Distribution

Permian Basin Royalty Trust Announces June Cash Distribution

DALLAS, June 18, 2019 /PRNewswire/ -- Simmons Bank, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) ("Permian") today declared a cash distribution to the holders of its units of beneficial interest of $0.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AVA, BWB, CCF, CXW Downgrades: ASH, GCAP, HTH, HZNP, MBTF, MOV, OFED, PBT, WOR Initiations: CUE, EQH, TALO, TMSR Read on to get TheStreet Quant Ratings' detailed report:

Permian Basin Royalty Trust Announces May Cash Distribution

Permian Basin Royalty Trust Announces May Cash Distribution

DALLAS, May 20, 2019 /PRNewswire/ -- Simmons Bank, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) ("Permian") today declared a cash distribution to the holders of its units of beneficial interest of $0.

Permian Basin Royalty Trust Is Now Oversold (PBT)

Permian Basin Royalty Trust Is Now Oversold (PBT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Permian Basin Royalty Trust Becomes Oversold (PBT)

Permian Basin Royalty Trust Becomes Oversold (PBT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Permian Basin Royalty Trust Announces April Cash Distribution And 2019 Reserve Quantities

Permian Basin Royalty Trust Announces April Cash Distribution And 2019 Reserve Quantities

DALLAS, April 18, 2019 /PRNewswire/ -- Simmons Bank, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) ("Permian") today declared a cash distribution to the holders of its units of beneficial interest of $0.

Alterity Therapeutics Launches To Asian Investors

Alterity Therapeutics Launches To Asian Investors

Alterity Therapeutics Limited, (formerly Prana Biotechnology Limited) (ASX: PBT, NASDAQ: ATHE) ("Alterity" or "the Company") is meeting this week with sophisticated investors in both Singapore and Hong Kong in the first leg of a global investor roadshow.

Permian Basin Royalty Trust Announces March Cash Distribution

Permian Basin Royalty Trust Announces March Cash Distribution

DALLAS, March 19, 2019 /PRNewswire/ -- Simmons Bank, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT) ("Permian") today declared a cash distribution to the holders of its units of beneficial interest of $0.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BCBP, CBFV, CIO, DDS, FBC, FLS, FORTY, HSTM, PBT, SWKS, WP Downgrades: CENT, COKE, EE, GPOR, PEB Initiations: JT Read on to get TheStreet Quant Ratings' detailed report:

Prana Receives First Orphan Drug Designation From The FDA For The Treatment Of Multiple System Atrophy

Prana Receives First Orphan Drug Designation From The FDA For The Treatment Of Multiple System Atrophy

Prana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) ("Prana" or "the Company") has today announced the US Food and Drug Administration (FDA) has granted Orphan Drug designation for its lead molecule, PBT434, for the treatment of Multiple System Atrophy (MSA).

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: None Downgrades: ABCB, ADSW, BY, CLGX, DSGX, IMO, JBT, KAMN, KBR, LBRDA, LBRDK, PBT, SF, WAL, WRD Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Permian Basin Royalty Trust Enters Oversold Territory (PBT)

Permian Basin Royalty Trust Enters Oversold Territory (PBT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

RSI Alert: Permian Basin Royalty Trust (PBT) Now Oversold

RSI Alert: Permian Basin Royalty Trust (PBT) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Prana Biotechnology: Pre-Clinical Evidence Demonstrates PBT434 As A Potential Treatment For MSA

Prana Biotechnology: Pre-Clinical Evidence Demonstrates PBT434 As A Potential Treatment For MSA

Prana Biotechnology Ltd (ASX: PBT) (NASDAQ: PRAN) today announced further pre-clinical evidence for PBT434 will be presented in a poster at the International Congress of Parkinson's Disease and Movement Disorders® in Hong Kong on Sunday, October 7 th,...

Permian Basin Royalty Trust Becomes Oversold

Permian Basin Royalty Trust Becomes Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Permian Basin Royalty Trust Becomes Oversold (PBT)

Permian Basin Royalty Trust Becomes Oversold (PBT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Permian Basin Royalty Trust (PBT) Shares Cross Above 200 DMA

Permian Basin Royalty Trust (PBT) Shares Cross Above 200 DMA

In trading on Monday, shares of Permian Basin Royalty Trust crossed above their 200 day moving average of $9.36, changing hands as high as $9.40 per share. Permian Basin Royalty Trust shares are currently trading up about 1.6% on the day.

PBT434 Data To Be Presented At The International Congress Of Parkinson's Disease And Movement Disorders

PBT434 Data To Be Presented At The International Congress Of Parkinson's Disease And Movement Disorders

Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) has today announced it will be presenting further pre-clinical evidence for PBT434 at the International Congress of Parkinson's Disease and Movement Disorders® to be held in Hong Kong from October 5-9, 2018.

First Volunteers Dosed In Phase I Clinical Trial Of PBT434, Prana's Lead Therapy For Parkinsonian Diseases

First Volunteers Dosed In Phase I Clinical Trial Of PBT434, Prana's Lead Therapy For Parkinsonian Diseases

Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) is pleased to announce the first cohort of volunteers in its Phase I clinical trial have been administered PBT434, an experimental drug under investigation for the treatment of Parkinsonian diseases.

Prana To Commence Phase 1 Clinical Trial Of PBT434 For Treatment Of Parkinsonian Diseases

Prana To Commence Phase 1 Clinical Trial Of PBT434 For Treatment Of Parkinsonian Diseases

Prana Biotechnology Ltd (ASX PBT: NASDAQ PRAN) is pleased to announce it has received ethics committee approval and has commenced recruitment for its Phase I Clinical trial evaluating the safety, tolerability and pharmacokinetics of the Company's lead...

Oversold Conditions For Permian Basin Royalty Trust (PBT)

Oversold Conditions For Permian Basin Royalty Trust (PBT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: OZM, PBT, PFSW, SON, UBOH Downgrades: EBR, EBR.B, RECN, TA Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

PBT Ex-Dividend Reminder - 11/29/17

PBT Ex-Dividend Reminder - 11/29/17

Looking at the universe of stocks we cover at Dividend Channel, on 11/29/17, Permian Basin Royalty Trust will trade ex-dividend, for its monthly dividend of $0.0510, payable on 12/14/17. As a percentage of PBT's recent stock price of $9.19, this dividend works out to approximately 0.56%, so look for shares of Permian Basin Royalty Trust to trade 0.56% lower — all else being equal — when PBT shares open for trading on 11/29/17.

PBT Crosses Above Key Moving Average Level

PBT Crosses Above Key Moving Average Level

In trading on Friday, shares of Permian Basin Royalty Trust crossed above their 200 day moving average of $8.91, changing hands as high as $8.93 per share. Permian Basin Royalty Trust shares are currently trading up about 1.6% on the day.

Oversold Conditions For Permian Basin Royalty Trust (PBT)

Oversold Conditions For Permian Basin Royalty Trust (PBT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

TheStreet Quant Rating: C (Hold)